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Cytokine- and LPS-induced synthesis of interleukin-8 from human
mesangial cells. The cytokine neutrophil-activating peptide-l/interleu-
kin-8 (NAP/IL-8) activates neutrophils (PMN) and elicits selective
diapedesis of PMN into the extracellular space. The glomerular mesan-
gial cell (MC) is a specialized pericyte that controls glomerular filtration
and synthesizes and responds to a variety of cytokines. Because of its
location within the glomerulus, the MC is in a pivotal position to
orchestrate events underlying immune injury. Since immune-injured
glomeruli have been shown to produce NAP/IL-8 activity in vitro, we
assessed whether lipopolysaccharide (LPS)- or cytokine-activated MC
might be a source of this activity. Pure human MC, devoid of monocyte!
macrophage and fibroblast contamination, were grown by explant from
collagenase-treated glomeruli. Human recombinant interleukin- Ia (IL-
in, 20 nglml), IL-lI3 (50 ng/ml), tumor necrosis factorn (TNF, 100
ng/ml) and lipopolysaccharide (LPS, 10 sg/ml) stimulated release of a
neutrophil chemotactic factor from cultured MC. Both concentrated
(fivefold) and unconcentrated MC supernatants stimulated directed
neutrophil migration under agarose at a level similar to that of the
bacterial chemotactic factor, FMLP. In contrast, unstimulated MC-
conditioned media and IL-la, IL-l)3, TNF and LPS in medium alone
did not directly induce PMN migration. Molecular sizing studies using
sequential membrane ultrafiltration identified significant TNF-stimu-
lated, MC-derived chemotactic activity in the 3000 to 10000 kD fraction.
An anti-NAP/IL-8 monoclonal antibody, 46E5, significantly inhibited
PMN chemotaxis stimulated by TNF-stimulated, MC-conditioned me-
dia in a dose-dependent manner. S1 nuclease analyses of a total RNA
extracted from TNF-stimulated MC showed a dose- and time-depen-
dent increase in NAP/IL-8 mRNA transcripts and demonstrated that a
chemotaxin, produced by cytokine- and LPS-stimulated MC, is highly
homologous to NAP/IL-8. Northern analysis of TNF-stimulated MC
RNA identified NAP-1/IL-8 transcripts in MC which comigrated with
the 1.8 kb message in LPS-stimulatcd human monocytes. Using 135S]la-
belIed oligonucleotide probes, NAP/IL-8 mRNA transcripts were dem-
onstrated in the cytoplasm of IL-l and TNF-stimulated, but not control,
mesangial cells. Taken together, these data demonstrate the human MC
synthesize and release NAP/IL-8, a potent chemotactic peptide for
PMN that may contribute to the structural and functional derangements
which occur in glomerular inflammation.
Neutrophil infiltration into the glomerulus is characteristic of
several forms of experimental and human glomerulonephritis
[1]. Although activated complement components result in the
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chemotaxis of neutrophils into the glomerulus [1], other
chemoattractant peptides and lipids are likely to participate in
this process. Enhanced synthesis of some of these mediators
has been demonstrated in experimental glomerular injury [1].
The recent discovery that the inflammatory cytokines interleu-
kin (IL)-1 and tumor necrosis factora (TNF), as well as lipo-
polysaccharide (LPS), stimulate a number of target cells to
release chemotactic peptides for leukocytes [2, 3], including
neutrophil activating peptide-1/interleukin-8 (NAPIIL-8), sug-
gested to us that NAP/IL-8 may be an important mediator of
glomerular immune injury. Consistent with this postulate, a
preliminary report has described increased NAP/IL-8 release in
vitro by immune-injured glomeruli isolated from rats with
nephrotoxic serum nephritis [41. In addition, infusion of either
IL- 1, TNF or LPS increases the severity of glomerular injury in
a neutrophil-dependent model of glomerulonephritis and causes
transient neutrophil margination in glomerular capillaries of
normal animals [51.
Local levels of IL-i and TNF are likely to be elevated in
immune-injured glomeruli. Enhanced IL-i and TNF gene
expression has been identified in several models of glomerulo-
nephritis [6—81. Increased IL-i activity has also been measured
in culture supernatants of glomeruli isolated from patients with
cresentic nephritis and from animals with focal, segmental
glomerulosclerosis and accelerated nephrotoxic serum nephritis
[9—111. Activated mononuclear leukocytes have been identified
in both acute and chronic glomerular injury [1] and are potential
sources of IL-i and TNF. In addition, cultured glomerular
mesangial cells (MC) synthesize IL-i and TNF [6, 12, 13].
Although NAP/IL-8 was originally isolated from supernatants
of LPS-stimulated monocytes, regulated production of this
peptide has been demonstrated in a number of other cell types
[2, 3]. We hypothesized that the MC, as part of its repertoire of
responses to inflammatory mediators, would produce NAP!
IL-8. The glomerular MC occupies a central anatomical posi-
tion in the glomerulus [141. Abundant in vitro evidence suggests
this cell can be induced to undergo a phenotype switch from a
contractile to an activated secretory phenotype [14], a process
which is likely to be a critical element in the restorative and
destructive processes that follow glomerular injury. IL-i, TNF
and LPS all activate the MC to express new structural and
functional characteristics [12, 15—171.
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Methods
Human MC culture and generation of MC-conditioned
medium
Human MC were grown from glomerular explants using
minor modifications of the procedure we have previously
published for cultured rat MC [6, 15]. Renal tissue was obtained
from normal portions of tumor nephrectomy specimens. Gb-
menili were isolated by sieving as we have previously described
[18] and incubated with collagenase (Type IV, Calbiochem, La
Jolla, California, USA) for 30 to 60 minutes. The resulting
glomerular "cores" were collected in a 75 j.tm nylon sieve and
cultured in Waymouth's medium (Gibco Laboratories, Grand
Island, New York, USA) supplemented with 17% fetal bovine
serum (FBS, Hycbone), 15 LM Hepes, 2 m glutamine, 1%
(vol/vol) sodium pyruvate (M.A. Bioproducts, Walkersville,
Maryland, USA), 1% (vol/vol) nonessential amino acids (M.A.
Bioproducts), insulin (5 g/ml), transferrin (5 pg/ml) and sele-
nium (5 ng/ml). The cells were subcultured using 0.25% trypsin
and 0.5 mi EDTA and used in passages 4 through 10. We have
characterized the cells using methods similar to those we have
used to characterize rat MC [6, 151, and our results are
concordant with the results published by other investigators
[14]. Under phase contrast microscopy, human MC are stellate
with cytoplasmic projections similar to rat MC. Electron mi-
croscopy demonstrated that all the cells examined had cytoplas-
mic filaments which were parallel to the plasma membrane and
which were organized into dense bodies adjacent to the plasma
membrane. Human MC, grown on LAB-TEK slides (Miles
Scientific, Naperville, Illinois, USA), stained by indirect immu-
nofluorescence [6] for the intermediate filaments desmin (Da-
kopatts, Carpenteria, California, USA), myosin (Shadrack Bi-
ologicals, Bromma, Sweden) and vimentin (Polysciences,
Warrington, Pennsylvania, USA), indicative of the mesenchy-
mal origin of the cells, but were negative for cytokeratin (Triton
Biosciences, Alameda, California, USA) and Factor VIII-
associated antigen (N.L. Cappel Laboratories, Cochranville,
Pennsylvania, USA), excluding epithelial and endothelial con-
tamination. The cells synthesize fibronectin (Boehringer-Mann-
heim, Indianapolis, Indiana, USA), which was organized into
matrix. Common leukocyte antigen (T-200, Dakopatts) and
Class II antigens (anti-DR framework, Boehringer-Mannheim)
also were not detected, making leukocyte contamination un-
likely. Appropriate positive controls were included; non-spe-
cific antibodies of the same isotype as the specific antibody
were used by negative controls. As reported by others [14],
these MC express LTD4 receptors.
At the time of the experiments, medium of cells in 75 cm2
flasks was changed, and fresh medium alone or containing the
indicated concentration of IL- 1 a, IL-i /3, TNF, or LPS was
added for the indicated time. At the end of the incubation, the
flasks were placed on ice and the medium removed and frozen
at —70°C until assay. The monolayers were washed and solu-
bilized and protein content determined as described [131. In
each experiment, variation in protein content between condi-
tions was less than 10%. The specific activity and endotoxin
content of the cytokines have been published previously [15,
161.
Preparation of neutrophils and monocytes
Neutrophils and mononuclear cells were isolated as de-
scribed [19, 20] from heparinized venous blood of healthy adult
donors by Ficoll-hypaque (Pharmacia Fine Chemicals, Piscat-
away, New Jersey, USA) density centrifugation. Mononuclear
cells were removed from the serum-gradient interface, while
PMN were recovered from the cell pellet by dextran sedimen-
tation (Pharmacia) and hypotonic lysis of contaminating eryth-
rocytes. The mononuclear cells were further fractionated into
adherent and nonadherent cells by incubation for one hour in
plastic plates at 37°C. The cells were kept chilled on ice in
Hanks' balanced salt solution (HBSS) without calcium and
magnesium (Gibco Laboratories) until use in the chemotaxis
assay (see below). Purity of neutrophil populations was as-
sessed by Wright-Giemsa staining and was greater than 95%.
The adherent cells were greater than 90% monocytes as esti-
mated by staining for non-specific staining. Viability deter-
mined by trypan blue exclusion was greater than 95%.
Chemotaxis assay
Chemotaxis of human PMN was assayed as described under
agarose [20, 21]. A total of 1.2 g of agarose (Accurate Chemical
and Scientific Corp., Westbury, New York, USA) was dis-
solved in 50 ml sterile, distilled water by heating in a boiling
water bath for 30 minutes. The agarose was cooled to 56°C and
mixed with an equal volume of 2 x minimal essential medium
with Earle's salt (MEM-lOX, Hazelton Biologies, Lenexa,
Kansas, USA) supplemented with heat-inactivated FBS,
NaHCO3, L-glutamine, penicillin and streptomycin. The final
concentrations of these reagents were: FBS, 10%; NaHCO3,
375 ,aglml; L-glutamine, 2.0 mM; penicillin, 400 p1mb; and
streptomycin, 400 g/ml. Five ml of agarose-medium solution
was pipetted into sterile 60 x 15 mm tissue culture plates, the
plates were cooled at 4°C for one hour and 2.4 mm wells were
cut with an Ouchterlony cylinder.
PMN were suspended in HBSS with calcium and magnesium
(Gibco) to a concentration of 2.5 X i07 cells ml'. Ten
microliters of cell suspension were placed in the middle well of
a three-well series. The outer well received 10 1d of the solution
to be tested for chemotactic activity: either n-formyl-met-leu-
phe (FMLP) (100 nM, Sigma Chemical Co.) or supernatants of
stimulated or unstimulated MC, stimulus in medium alone, or
medium alone. Prior to assay, MC-conditioned media as well as
the media controls were heat treated for 30 minutes at 56°C to
remove C' activity. The inner well received 10 p1 of HBSS. The
plates were placed in a 37°C humidified incubator with 5% CO2
for two hours. Following incubation, the cells were fixed by
adding 3 ml of absolute methanol (Fisher Scientific Co., Fair
Lawn, New Jersey, USA) for 30 minutes followed by 3 ml of
10% buffered formalin acetate (Fisher) for 30 minutes. After
fixation, the gel was removed and the plates were stained with
Wright-Giemsa. Chemotactic activity was determined as the
distance of PMN migration toward the outer well minus that
toward the control medium and expressed as the percentage of
the FMLP (100 nM) control response. In some experiments,
supernatants from control and stimulated MC were size-frac-
tionated by sequential ultrafiltration using a Centricon-lO and
Centricon-3 filter (W.R. Grace and Co., Danvers, Massachu-
setts, USA). Chemotactic activity was measured in each frac-
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tion: molecular weight (MW) < 3 kD, 3 kD < MW < 10 kD, and
MW > 10 kD. TSK-2000-HPLC confirmed the MW of the
proteins contained in each fraction. In other experiments, serial
dilutions of the specific mouse anti-human NAP/IL-8 monoclo-
nal antibody 46E5 [22] (provided by Dr. M. Sticherling and
Prof. Dr. med. E. Christophers) or isotype-matched control
monoclonal IgG1 were added to the MC supernatants prior to
performing the chemotaxis assay and incubated for 30 minutes
at 23°C. Mouse IgG titers in the control and specific hybridoma
supernatants were comparable as estimated in an Ouchterlony
diffusion assay.
S1 nuclease and Northern analysis
Homology between NAP-l and the MC neutrophil chemotac-
tic factor was assessed by S1 nuclease analysis; transcript size
was assessed by Northern analysis. S1 nuclease and northern
analysis were performed as we have previously described with
minor modifications (Nakazato, Y., M. Simonson, W. Herman,
M. Konieczkowski and J.R. Sedor, manuscript submitted for
publication). Briefly, total monocyte and MC RNA were ex-
tracted using 4 M guanidine isothiocyanate buffer and purified
by ultracentrifugation through a cesium chloride cushion [6]. A
30-nucleotide (nt) probe for human NAP/IL-8, previously de-
scribed by Streiter et al [23], was synthesized with a cDNA
sequence that was complementary to nt 262-291 and had the
sequence 5'-GGC-TGG-GGT-GTT-GAA-GGT-CTC-AAA-CAT-
GAT-CTG-GGT-CAT-CTT-3'. The 30-mer was 5' end-labelled
using standard techniques with [y-32P]adenosine 5'-triphos-
phate (NEN, Boston, Massachusetts, USA) to a specific activ-
ity greater than 108 cpm/tg. Unincorporated label was removed
by repeated (x 3) ethanol precipitation. Ethanol-precipitated
aliquots (7.5 g) of total MC RNA or RNase-free yeast transfer
RNA (tRNA) were suspended in 30 d of hybridization buffer
containing l0 cpm of [32P]labelled 30-mer in aqueous hybrid-
ization buffer (1 M NaCI 167 mM Hepes, pH 7.5, and 33.5 /LM
EDTA, pH 8.0). In each assay, [32Pilabelled probe was hybrid-
ized with total RNA (I .tg) extracted from human monocytes
stimulated with LPS for six hours as a positive control for
NAP/IL-8 expression. The samples were heat-denatured for 10
minutes at 75°C and then hybridized overnight at 49°C for 16
hours. Following hybridization, unprotected single-stranded
RNA was digested by 100U S1 nuclease (Boehringer Mann-
heim) for 30 minutes at 18°C in 300 1.d of a buffer containing 1.4
M NaCI, 250 m sodium acetate, pH 4.5, and 22.5 mrs'i ZnSO4.
Digestion was terminated by adding 3 d 0.5 M EDTA, 700 .d
ethanol and 25 ig yeast tRNA. After ethanol precipitation, the
[32P}labelled 30-mer-RNA hybrid was dissolved in 0.1 M NaOH,
denatured and analyzed by electrophoresis through 15% dena-
turing polyacrylamide gels. Autoradiograms were obtained by
exposing the gels to Kodak XAR-5 film for 2 to 16 hours.
Northern analysis was used to size NAP-1/IL-8 transcripts as
previously described with modifications [6]. Total cellular RNA
from cytokine-stimulated human MC and LPS-stimulated hu-
man monocytes was fractionated on 1% agarose, 0.66 M form-
aldehyde gels and transferred by capillary blotting with lox
SSPE (lx SSPE: 180 m NaCl, 10 mM Na2HPO4 7H20, and
1 mM EDTA). After rinsing in 2x SSPE, the blots were
prehybridized (50 pi/cm2) for six hours at 49°C in 6x SSPE, 5 x
Denhardt's solution, 0.1 M Na2HPO4 (pH 6.8), 0.1 M EDTA,
0.05% sodium dodecyl sulfate (SDS), 200 Wml yeast tRNA
and 100 g!ml denatured, salmon sperm DNA. The blots were
hybridized overnight at 49°C in the same buffer containing heat
denatured, [32P}labelled-NAP/IL-8 oligonucleotide probe (4
pmoles). The filter was subsequently washed twice at room
temperature for five minutes in 6x SSPE and once at 68°C (Tm
minus 5°C) for 10 minutes in 6x SSPE. Autoradiography was
performed as described above. Transcript sizes (kb) were
determined from an mRNA ladder of known fragment sizes
(Bethesda Research Labs, Gaithersburg, Maryland, USA).
In situ hybridization
In situ hybridizations of human MC with NAP/IL-8 probe
were performed as described [6] with the following modifica-
tions. The cells were fixed in 4% paraformaldehyde for 10
minutes. The NAP/IL-8 probe was 3'-end labelled with
[35S]dUTP (NEN) to specific activities > 108 cpm/jg using
terminal deoxynucleotidyltransferase. The cells were prehy-
bridized at room temperature for one hour in 0.3 M NaC1, 0.1 M
Tris HCI, pH 7.5, 0.01 M EDTA, lx Denhardt's solution, 50%
deionized formamide, 100 mrvi dithiothreitol, 500 g/ml yeast
total RNA, 50 ug/mi yeast tRNA and 50 pg/ml single stranded
DNA, The slides were subsequently drained, and the cells were
hybridized overnight at room temperature (Tm minus 10°C) in
prehybridization buffer (50 d) containing 10% polyethylene
glycol (—MW 8000) and 4 ng (106 cpm) of probe. The slides
were then washed with constant agitation at room temperature
for 30 minutes with 2x SSPE, 1% Na2SO4 and 0.1% /3-mercap-
toethanol, at 42°C for 60 minutes with lx SSPE, 1% Na2SO4
and 1% /3-mercaptoethanol, and at room temperature for 15
minutes with 2x SSPE. The slides were processed for autora-
diography, exposed, developed and counterstained as previ-
ously described [6]. We used a Nikon-Microphot Fx micro-
scope for dark field and light field microscopy. Grains over cells
were quantified as previously described [61.
Results
Cytokine- or LPS-stimulated mesangial cells release a
neutrophil chemotactic factor
IL-la (20 ng/ml), IL-l/3 (50 ng/ml), TNF (100 nglml) and LPS
(10 g/m1) all stimulated MC to release a neutrophil chemotactic
factor into culture supernatants following a 24-hour incubation
period (Fig. 1, solid bars). The directed migration induced by
the MC-derived neutrophil chemotactic factor was greater than
that stimulated by the bacterial chemotactic peptide, FMLP
(100 nM). Chemotaxis elicited by unconcentrated, TNF-, IL-
1/3-, IL-la- and LPS-stimulated MC supernatants was 123
10% (mean SE, N = 18), 125 23% (N 6), 153 18% (N
= 6) and 122 21% (N = 6), respectively, of the response
elicited by FMLP. Supernatants of unstimulated cells did not
contain any neutrophil chemotactic activity, and there was no
chemotaxis in response to indicated stimuli in medium that had
not been conditioned by MC (Fig. 1, open bars). Chemotactic
activity in these samples was consistently less than 5% of the
response elicited by FMLP.
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Stimulus tested
Fig. 1. Cytokine- and LPS-stimulated MC release a chemotactic factor
for neutrophils. Human MC were incubated for 24 hours with vehicle,
TNF (100 nglml), IL-1J3 (50 nglml), IL-icr (20 ng/ml), or LPS (10 .cgIml).
The chemotaxis induced by the various cytokines and LPS was
quantified as described in Methods and expressed as a percentage of the
FMLP-stimulated response. Data presented are the mean sa of two to
six experiments, each determined in triplicate, assessing the chemotac-
tic activity released into MC-conditioned medium. Closed bars show
migratory response to MC-conditioned medium with the indicated
stimulus or vehicle control. Open bars represent response to the
cytokines or LPS in medium not conditioned by MC.
Kinetic analysis and dose dependence of mesangial cell-
derived neutrophil chemotactic factor released in response to
TNF
Figure 2A (solid bars) presents a representative time course
of neutrophil chemotactic factor activity released by TNF (100
nglml)-stimulated MC. At specific time intervals, supernatants
and mRNA (see below) were recovered. TNF-stimulated MC
released a chemotactic factor (19% of the FMLP response) as
early as one hour, with significant chemotactic bioactivity
(about 40% of FMLP-stimulated response) being produced after
four and eight hour incubations. The chemotactic activity
continued to rise, and by 24 hours the migration elicited by
supernatants of TNF-stimulated MC was similar to the re-
sponse induced by FMLP (100 nM). No significant chemotactic
activity (< 5% of FMLP-stimulated response) was detectable in
cells maintained in culture medium containing vehicle alone
(Fig. 2A, hatched bars). Release of neutrophil chemotactic
activity in response to TNF was dose dependent (Fig. 2B, solid
bars). In 24 hour incubations, as little as 0.1 nglml TNF
markedly increased the chemotactic activity (29 11%, mean
SE, of the FMLP response) in MC supernatants (Fig. 2B,
solid bars). Chemotaxis induced by supernatants of MC cells
incubated with 1, 10 and 100 nglml TNF was 94 8% (mean
SE, N = 6), 105 13% (N = 6) and 124 16% (N = 6),
respectively, of the FMLP (100 nM) response. In contrast, TNF
alone had no chemotactic activity (less than 5% of the FMLP
response) at any of the concentrations tested (Fig. 2B, hatched
bars).
Size fractionation and specficily of the MC neutrophil
chemotactic factor
To characterize the chemotactic factor released by TNF-
stimulated MC, we measured chemotactic activity in medium
T4J1
Stimulation time, hours
rTNFa, ng/m/
Fig. 2. TNF stimulates MC to release a neutrophil chemotactic factor
in a time-dependent and dose-responsive manner. (A) Time course.
Cells were incubated with TNF (100 ng/ml, closed bars) or with vehicle
(hatched bars) for the indicated times. The data presented in the figure
are representative of two experiments, each assayed in triplicate. (B)
Dose-response. Cells were incubated with the indicated concentration
of TNF (closed bars) or with vehicle (hatched bars) for 24 hours. The
data are mean SE of chemotactic activity found in supernatants of two
experiments, each assayed in triplicate. Neutrophil chemotaxis stimu-
lated by the supernatants in both (A) and (B) is quantified as described
in Figure 1.
that had been fractionated by sequential membrane ultrafiltra-
tion to separate the proteins into three groups: those smaller
than 3 kD, those between 3 to 10 kD and those larger than 10 kD
(Table 1). The 3 kD pass-through contained no chemotactic
activity. However, a neutrophil chemotactic factor(s) was
present in equivalent amounts in both the 3 to 10 kD fraction
and the 10 kD retentate (Table 1). The release of chemotactic
activity by TNF-stimulated MC was time-dependent in both the
3 to 10 kD and> 10 kD fractions.
The molecular weight of purified NAP-1/IL-8 ranges from 6 to
8 kD [2, 31, suggesting that the chemotactic activity detected in
the 3 to 10 kD fraction of TNF-stimulated MC supernatants may
have resulted from MC synthesis of NAP/IL-8. The chemotac-
tic activity in the 10 kD retentate was not further studied but
could represent oligomers of NAP/IL-8 or NAP/IL-8-like pep-
tides as well as larger MC-derived proteins that induce neutro-
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Table 1. Size fractionation of neutrophil chemotactic activity in supernatants of TNF-stimulated MC
Control %b TNF-stimulated %b
MW lcD 1 hr 3 hr 6 hr 24 hr 1 hr 3 hr 6 hr 24 hr
>10 5±3 1±3 2±5 5±4 —1±2 22±10 65±13 86±5
3—10 —2±4 5±3 5±3 12±7 7±5 27±6 31±8 56±8
<3 2±3 2±2 4±4 —2±3 2±2 5±3 6±6 —1±6
Mesangial cell-conditioned medium was fractionated by serial membrane ultrafiltration using Centricon-3 and Centricon-lO as described in
Methods.
b Data (mean SE) show neutrophil chemotactic activity in supernatants of vehicle (0.1% BSA)- and TNF (100 ng/ml)-stimulated MC which has
been normalized as percent of the migratory response to FMLP (100 nat). N = 2 to 6 replicates in two separate experiments.
CTL 1:1
Antibody dilution tested
Fig. 3. Anti-NAP/IL-8 (46E5) inhibits TNF-stirnulated MG-derived
neutrophil chemotactic factor. In three experiments, supernatants of
MC stimulated for 24 hours with TNF (100 ng/ml) were mixed with the
monoclonal antibody 46E5 to achieve the indicated dilution. Chemo-
tactic activity was then assayed and quantified as described in Methods.
Supernatants were also mixed with a control (CTL), isotype matched,
monoclonal IgG1.
phi! chemotaxis. To identify the 3 to 10 kD chemotaxin as
NAP/IL-8, we used a specific anti-NAP/IL-8 antibody, desig-
nated 46E5 [22]. 46E5 produced a dose-dependent inhibition of
the TNF-stimulated, MC-derived neutrophil chemotactic factor
(Fig. 3). A 1:1 dilution of the antibody inhibited the chemotactic
activity in the 3 to 10 kD fraction of the culture supernatants by
60 6% (N 6). A 1:10 dilution inhibited chemotaxis by 13
10% (N = 6) and a 1:100 dilution of the antibody did not reduce
significantly the chemotactic activity in culture supernatants.
An isotype-matched control monoclonal IgG1 had no significant
effect on TNF-stimulated MC chemotactic activity (Fig. 3). We
conclude from these experiments that TNF-stimulated MC
synthesize and release NAP!IL-8 bioactivity.
Cytokine- and LPS-stimulated mesangial cells contain NAP!
IL-8 mRNA transcripts
To further characterize the MC-derived chemotactic factor as
NAP/IL-8, we next exploited the sensitivity and specificity of
solution hybridization (Methods) to determine levels of NAP!
IL-8 mRNA transcripts in cytokine-stimulated MC. A number
of related, low molecular weight chemotactic peptides have
been described [3]. The 30-mer oligonucleotide probe used in
these studies was derived from a region of NAP!IL-8 (amino
acid 54-63) that lacks homology with other members of the
macrophage inflammatory protein superfamily [6], allowing
specific identification of NAP/IL-8 mRNA. We first determined
the presence and time-dependence of NAP!IL-8 mRNA expres-
sion in TNF (100 ng/ml)-stimulated MC. TNF stimulated
expression of NAP/IL-8 mRNA in MC in a time-dependent
manner (Fig. 4). NAP!IL-8 mRNA was easily detectable in MC
incubated with TNF for one hour (Lane 6, Fig. 4) and progres-
sively at four hours (Lane 7, Fig. 4) and 24 hours (Lane 8, Fig.
4). MC maintained in culture medium containing vehicle did not
express NAP!IL-8 mRNA at corresponding time points (Lanes
3 to 5, Fig. 4). The probe used also hybridized with NAP/IL-8
mRNA transcripts in LPS-stimulated macrophages (Lane 2,
Fig. 4). To quantify more precisely levels of MC NAP!IL-8
mRNA expression in control and TNF-stimulated cells, the
bands of interest were cut out of the gels and solubilized and the
radioactivity counted (Fig. 4B). The results obtained confirmed
the interpretation of the autoradiogram.
We next confirmed by solution hybridization that LPS- and
IL-I -stimulated MC also express NAPIIL-8 mRNA transcripts
and established the dose-dependence of MC NAP!IL-8 expres-
sion in response to TNF. MC were incubated for 24 hours with
vehicle, TNF (0.1 to 100 ng/ml), IL-la (80 ng!ml), IL-113 (50
ng/ml) and LPS (10 p,g!ml) (Fig. 5). No NAP/IL-8 mRNA
transcripts were identified in yeast tRNA (Fig. 5A, Lane 1) or
cells maintained in medium alone (Fig. 5A, Lane 2). In contrast,
LPS (Fig. 5A, Lane 3), TNF (Fig. 5A, Lanes 4 to 7), IL-la (Fig.
5A, Lane 8) and IL-1f3 (Fig. 5A, Lane 9) all stimulated NAP!
IL-8 mRNA expression. LPS was less potent than the cytokines
in inducing NAP!IL-8 gene expression. The effect of TNF was
dose-dependent (Fig. 5A, Lanes 4 to 7). Total RNA extracted
from LPS (10 g/ml)-stimulated human monocytes was in-
cluded as a positive control (Fig. 5A, Lane 10). Relative levels
of NAP/IL-8 expression in MC were again quantified as de-
scribed above and the results are depicted in Figure SB.
To size the hybridizing NAP!IL-8 message in human MC, a
Northern blot was hybridized under high stringency conditions
with the same oligonucleotide probe used in the preceding
solution hybridization analyses. Total RNA (7.5 g) from TNF
(100 ng!ml)-stimulated (Fig. 6, Lane 3), but not control (Fig. 6,
Lane 2), MC contained NAPIIL-8 mRNA transcripts which
comigrated with the NAP!IL-8 mRNA species identified in
RNA (1 g) extracted from LPS (10 pg!ml)-stimu1ated human
monocytes (Fig, 6, Lane 1).
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Fig. 4. TNF stimulates NAP/IL-8 expression in MC. (A)
Total RNA was extracted from cells incubated with vehicle
(1 hr: Lane 3, 4.5 hr: Lane 4, and 24 hr: Lane 5) and with
TNF (100 ng/ml) for 1 hr (Lane 6), 4.5 hr (Lane 7) or 24 hr
(Lane 8). NAP/IL-8 expression was quantified by solution
hybridization (see Methods) using 7.5 g total MC RNA or
1 g total RNA extracted from LPS-stimulated human
monocytes (Lane 2). Probe was also hybridized with yeast
tRNA (Lanes 1 and 9). (B) NAP/IL-8 expression was
quantified by cutting out, solubilizing and counting the
bands of interest in a liquid scintillation counter.
Fig. 5. NAP/IL-8 expression in cytokine- and LPS-
stimulated MC. Total RNA was extracted from cells
incubated for 24 hours with vehicle (Lane 2), LPS
(10 ng/ml, Lane 3), TNF (0.1, 1, 10 and 100 nglml,
Lanes 4 to 7, respectively), IL-la (20 ng/ml, Lane 8)
and IL-1f3 (50 ng/ml, Lane 9). NAP/IL-8 expression
was quantified by solution hybridization (see
Methods) in 7.5 g total MC RNA. As a positive and
negative control, probe was hybridized to 1 g LPS-
stimulated human monocyte RNA (1 sg, Lane 10)
and yeast tRNA (7.5 jig, Lane 1), respectively. (B)
NAP/IL-8 expression was quantified as described in
Figure 4.
Visualization of NAP/IL -8 mRNA in human mesangial cells
by in situ hybridization
MC were incubated for 24 hours with vehicle, TNF (100
ng/ml) or IL-la (20 tg/ml) and NAP/IL-8 gene expression was
assessed by in situ hybridization. Representative fields of cells
are shown in Figure 7 using light (panels A, C, E) and dark field
microscopy (panels B, D, F). Grain are randomly distributed
over the cytoplasm and surrounding matrix of cells maintained
in medium alone (Fig. 7, panels A and B). In contrast, grains are
condensed over both TNF (Fig. 7, panels C and D)- and IL-l
(Fig. 7, panels E and F)-stimulated cells. Areas devoid of cells
have no more grains than background (Fig. 7, panels A and B).
Grain counting was performed on the best technical prepara-
tion. TNF-stimulated cells contained 80.3 4.5 grains/cell
(mean SE, N = 15), IL-I-stimulated cells contained 48.7 3.2
grains/cell (mean SE, N = 11), whereas unstimulated cells
contained only 6.2 0.4 grains/cell (mean SE, N = 26). We
also quantified grains contained in a standard area (10 mm2) in
regions devoid of MC (emulsion background) as well as over
clusters of cells. Grains over cytokine-stimulated MC were
approximately tenfold greater than emulsion background (data
not shown). In contrast, grain counts over control MC were
indistinguishable from emulsion background.
Discussion
Leukocyte chemoattractant factors are likely to be important
mediators of glomerular immune injury. Since several reports
[2, 31 have demonstrated that these cytokines and LPS stimu-
late other cell types to synthesize and release leukocyte che-
motactic factors, including NAP/IL-8, we hypothesized that
LPS- and cytokine-stimulated MC would release neutrophil
chemotactic peptides as part of their repertoire of responses to
IL-l and TNF. Recent data have suggested strongly that the
glomerular MC participates in both the restorative and destruc-
tive processes that follow glomerular immune injury [141. Both
IL-l and TNF mRNA are expressed in the injured kidney [6—8],
and IL-i, TNF and LPS can alter the degree of glomerular
injury when infused [5, 241, and induce profound structural and
functional changes in MC [12, 14—17]. Release of IL-l and TNF
could result either from infiltrating macrophages, a character-
istic of both immune and "non-immune" glomerular injury [11,
as well as from the MC themselves [6, 12, 131.
In this paper, we present evidence that cultured human MC
synthesize and release, in a regulated manner, the neutrophil
chemotactic peptide NAP/IL-8. Supernatants of cytokine- and
LPS-stimulated MC contained a neutrophil chemotactic fac-
tor(s). Production of this chemotactic activity in response to
TNF was dose- and time-dependent. An anti-NAP/IL-8 but not
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Fig. 6. A Northern blot analysis depicting NAPIIL-8 transcripts in
control and TNF-stimulated MC and LPS-stimulated human mono-
cytes. Total RNA from LPS-stimulated (6 hr) human monocytes (1 g,
Lane 1), control (7.5 g, Lane 2) and TNF-stimulated (100 ng/ml, 24 hr)
MC (7,5 sg, Lane 3) was hybridized with {32PjIabelled NAP/IL-8 probe
(see Methods). The hybridizing transcripts were sized using commer-
cially available markers (indicated in kb on left). The extent of migra-
tion of the 28S and 18S ribosomal subunits is shown on the right side of
the blot. LPS-stimulated monocytes and TNF-stimulated but not con-
trol MC contain a 1.8 kb NAP/IL-8 transcript. The ethidium bromide-
stained agarose gel is shown in the lower panel.
control monoclonal antibody significantly inhibited the chemo-
tactic activity of the TNF-stimulated glomerular MC superna-
tants in a dose-dependent manner. We also specifically identi-
fied NAP/IL-8 mRNA transcripts by solution hybridization in
cytokine- and LPS- but not vehicle-stimulated MC. Northern
blot analysis, using a NAP/IL-8 oligomer as a probe, demon-
strated a 1.8 kb hybridizing species in TNF-stimulated MC,
which comigrated with the NAP/IL-8 mRNA transcript in
LPS-stimulated human monocytes. In situ hybridization analy-
sis showed that MC incubated with IL-i and TNF for 24 hours
contained abundant NAPIIL-8 transcripts, whereas unstimu-
lated cells were negative.
In contrast to fibroblasts and hepatocytes [25, 26], LPS
stimulated MC NAP/IL-8 gene expression and bioactivity, a
finding that confirms that the cells studied were not of fibroblast
lineage. Thornton et al have postulated that immune cells, such
as macrophages, but not "non-immune cells", such as fibro-
blasts, produce NAP/IL-8 in response to LPS [261. The MC
occupies a central anatomical position within the glomerulus
and has traditionally been viewed as a pericyte. More recently,
numerous in vitro studies have demonstrated that these cells
have many characteristics of monocyte-macrophages [141. The
ability of LPS to regulate NAP/IL-8 mRNA and bioactivity
adds further support to the concept that MC, in response to
inflammatory injury, can undergo a switch from a contractile to
an immune-effector phenotype. Others have also shown that
bacterial cell wall components, including LPS, activate MC to
produce prostaglandins and cytokines [17], and to induce rapid
cytoskeletal reorganization and gene expression [271.
We have characterized a MC-derived neutrophil chemotactic
factor as NAP/IL-8, but two pieces of evidence suggest that
cytokine-activated MC also release other chemotactic peptides.
First, using a neutralizing NAP/IL-8 antibody, we were only
able to inhibit by 60 4% the chemotactic activity in the
supernatants of TNF-stimulated MC. Second, supernatants of
TNF (0.1 J.Lg/ml)-stimulated MC induced a small but reproduc-
ible neutrophil chemotactic response (Fig. 2B), but we were
unable to identify NAP/IL-8 mRNA transcripts in RNA ex-
tracted from the same cells (Fig. 5A). Although both of these
findings could be explained by technical limitations of the
assays (that is, antibody concentration is inadequate to totally
inhibit NAP/IL-8 bioactivity, and the quantity of NAP/IL-8
mRNA transcripts in cells stimulated by 0.1 nglml TNF are
below the detection limit of the assay), we believe that activated
MC secrete other chemotactic factors which may be related to
NAP/IL-8. NAP/IL-8 is a member of a large family of cytokines
that are structurally related and may have derived from a
common ancestral gene [31. The current studies were not
structured to test this hypothesis or the equally likely possibility
that activated MC secrete factors chemotactic for other types of
cells.
Although classical immune mechanisms initiate glomerular
immune injury [1], the subsequent mechanisms by which gb-
merular inflammation progresses to scar and fibrosis are un-
clear. MC synthesis of NAP/IL-8 may mediate, in part, this
process of injury. We speculate that the microenvironment of
the injured glomerulus contains cytokines such as IL-l and
TNF which signal the MC to synthesize NAP/IL-8. A prelimi-
nary report has demonstrated enhanced NAP/IL-8 synthesis by
immune-injured glomeruli [41. One function of this peptide
would be to induce neutrophil accumulation and activation
within the diseased kidney. A more intriguing notion is that
NAP/IL-8 has undescribed functions as an intercellular signal
during the inflammatory response. Consistent with this postu-
late, the time course of NAP/IL-8 production by nephritic
glomeruli occurs subsequent to neutrophil infiltration [4], sug-
gesting other glomerular actions for this peptide. Other evi-
dence has also been published establishing NAP/IL-8 activities
in addition to neutrophil chemotaxis and activation. NAP/IL-8
is now known to be chemotactic for lymphocytes [281. An
amino-terminal variant NAP/IL-8 derived from endothelial cells
as well as leukocyte-derived NAP/IL-8 inhibits neutrophil ad-
hesion to cytokine-activated endothelial monolayers and pro-
tects these endothelial cells from neutrophil-mediated damage
[29]. Taken together, these and other [2, 3] studies demonstrate
that NAP/IL-8 and related isoforms have a broad range of
proinflammatory as well as specific anti-inflammatory activities
that may be critical in the pathogenesis of glomerulonephritis.
Historically, the MC has been regarded as unifunctional and
only important in the regulation of glomerular filtration rate.
This study demonstrates that cultured human MC abundantly
express NAP/IL-8 in a regulated manner and provides further
evidence for the plasticity of the MC phenotype in vitro. The
present findings suggest that the MC is a key participant in
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Fig. 7. In situ hybridization of human MC with a 3'[35Sjend-labelled NAP/IL -8 probe. Cells were incubated for 24 hours with vehicle (panels A
and B), TNF (100 ng/ml, panels C and D) and IL-la (20 ng/ml, panels E and F) and processed for in situ hybridization as described in Methods.
The panels are representative of results in two separate experiments. The same field was photographed using light field (panels A, C, E) and dark
field (panels B, D, F) microscopy (magnification 400x).
generating and responding to a network of polypeptide cyto-
kines, which are important in the pathogenesis of glomerulone-
phritis. Future experimentation is needed to study the structure
of these MC-derived molecules and to characterize the full
range of their bio-activities, both in vivo and in vitro. The
abundant, regulated expression of NAP/IL-8 suggests that this
peptide will be an important signal in cell-cell communication in
the injured kidney, and we expect that as its biological activities
S.
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are defined, NAP/IL-8 production will characterize not only
disease processes mediated by neutrophil infiltration but also
other types of tissue injury.
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